Medicare Enrolled
Dr. David Goldfarb, MD
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goldfarb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldfarb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goldfarb
Dr. David Goldfarb is an urology physician in Houston, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Goldfarb performed 5,953 Medicare services across 3,422 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldfarb received a total of $25,908 from 70 pharmaceutical and/or device companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldfarb is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 19% volume in TX
$25,908 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,953
Medicare services
Top 19% in TX for urology physician
3,422
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~372 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,316 | $46 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,252 | $91 | $135 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
657 | $8 | $8 |
| Leuprolide injectable, camcevi, 1 mg | 546 | $63 | $80 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
270 | $8 | $11 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
268 | $2 | $2 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
228 | $6 | $15 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
189 | $298 | $387 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
187 | $159 | $201 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
155 | $27 | $68 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
144 | $109 | $173 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
79 | $56 | $250 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
68 | $96 | $131 |
| Injection, garamycin, gentamicin, up to 80 mg | 57 | $2 | $3 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
55 | $95 | $255 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
54 | $25 | $38 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $148 | $184 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $11 | $15 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
44 | $63 | $79 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
44 | $25 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $135 | $197 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $65 | $98 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
35 | $57 | $82 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
29 | $571 | $1,799 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
24 | $72 | $93 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $23 | $35 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $65 | $85 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $51 | $64 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $594 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,908
Total received (2018-2024)
Avg $3,701/year across 7 years
Top 10% in TX for urology physician
70
Companies
592
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,184 (50.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,724 (49.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,193
2023
$7,843
2022
$8,726
2021
$1,313
2020
$1,311
2019
$2,070
2018
$1,452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$12,142
Boston Scientific Corporation
$1,723
BIOTISSUE HOLDINGS INC.
$1,701
Astellas Pharma US Inc
$1,199
Terumo Medical Corporation
$771
PFIZER INC.
$639
BOSTON SCIENTIFIC CORPORATION
$634
Sumitomo Pharma America, Inc.
$629
Janssen Biotech, Inc.
$558
Myriad Genetic Laboratories, Inc.
$465
ABBVIE INC.
$463
Antares Pharma, Inc.
$404
Amgen Inc.
$356
PROCEPT BioRobotics Corporation
$308
Allergan Inc.
$233
Myovant Sciences Inc.
$223
Avadel Specialty Pharmaceuticals, LLC
$209
Endo Pharmaceuticals Inc.
$195
Dendreon Pharmaceuticals LLC
$193
Progenics Pharmaceuticals, Inc.
$174
BIOTISSUE HOLDINGS, INC.
$171
AbbVie, Inc.
$170
Axonics, Inc.
$151
Ferring Pharmaceuticals Inc.
$147
Allergan, Inc.
$144
UROVANT SCIENCES INC
$142
Ambu Inc.
$124
Aytu BioScience, Inc
$98
Smith+Nephew, Inc.
$97
TOLMAR Pharmaceuticals, Inc.
$97
ACCORD HEALTHCARE, INC.
$95
Axonics Modulation Technologies, Inc.
$74
Laborie Medical Technologies Corp.
$73
AbbVie Inc.
$64
Coloplast Corp
$60
Teleflex LLC
$58
Checkpoint Surgical, Inc
$57
Endo USA, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$50
Verity Pharmaceuticals Inc.
$48
Blue Earth Diagnostics Limited
$45
Bayer Healthcare Pharmaceuticals Inc.
$42
Avanos Medical
$38
UroGen Pharma, Inc.
$37
Medtronic, Inc.
$35
Novartis Pharmaceuticals Corporation
$30
BioTissue Holdings, Inc.
$29
C. R. Bard, Inc. & Subsidiaries
$28
PROGENICS PHARMACEUTICALS, INC.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
UROGEN PHARMA, INC.
$26
Tolmar, Inc.
$25
AstraZeneca Pharmaceuticals LP
$24
Merck Sharp & Dohme LLC
$24
Supernus Pharmaceuticals, Inc.
$22
Alafair Biosciences, Inc.
$22
ACELL, INC.
$21
Pacira Pharmaceuticals Incorporated
$21
Olympus America Inc.
$20
RGH Enterprises, Inc.
$19
Provepharm Inc.
$19
Abbott Laboratories
$19
Mission Pharmacal Company
$19
Metuchen Pharmaceuticals
$18
MILLICENT US INC
$16
AKRIMAX PHARMACEUTICALS, LLC
$15
Baxter Healthcare
$14
NxThera, Inc.
$13
EDAP TECHNOMED INC
$12
Retrophin, Inc.
$9
Top 3 companies account for 60.1% of total payments
Associated products mentioned in payments ›
(815) Thiola · AFINITOR · AMBICOR · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS Ambicor · ANGIO-SEAL · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AZUR CX DETACHABLE · Androgel · Axium INS DRG IPG · Axonics · Axonics r-SNM System · Axumin · BLUDIGO · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · Bard Urinary Drainage Bag · CAMCEVI · CERVIDIL · CLENPIQ · Checkpoint Stimulators · DA VINCI SP · Da Vinci Surgical System · ELIGARD · ERLEADA · EVENITY · EXPAREL · Erleada · FEMRING · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · GLIDEWIRE · HYDROPEARL · INTERSTIM · JELMYTO · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ON-Q* PUMP AND ACCESSORIES · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROKERA · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum · STRAVIX PL · SpaceOAR VUE System - 10mL · Stendra · Swiss LithoClast Triology · TACTRA · TISSEEL · TITAN · TOVIAZ · ThunderBeat · Tlando · Trelstar · UROLIFT · Uribel · VESICARE · VersaWrap · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for urology physician in TX.
Equivalent to $435 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
198
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Goldfarb is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 10% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Goldfarb experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Goldfarb performed 1,316 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldfarb receive payments from pharmaceutical companies?
Yes. Dr. Goldfarb received a total of $25,908 from 70 companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldfarb's costs compare to other urology physicians in Houston?
Dr. Goldfarb's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldfarb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BIOTISSUE HOLDINGS INC. Payments to Doctors
See all physicians who received payments from BIOTISSUE HOLDINGS INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology